Study of Roxadustat in the Treatment of Acute Myocardial Infarction
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 158 participants.
Also called NCT04803864
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 158 participants
- Sponsor
- Registry
-
NCT04803864
-
- Other papers using this trial's data
- Roxadustat Treatment After PCI Among Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04803864. Randomized; single masking; primary purpose treatment. Start 2021-06-10 (actual); primary completion 2022-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of Roxadustat in the Treatment of Acute Myocardial Infarction
- Acronym
- ROXAMI
- Condition
- ST Elevation Myocardial Infarction
- Intervention (Drug)
- Roxadustat
- Lead sponsor
- Ruijin Hospital
Record details
- Record id
cardio:ct-nct04803864- Content hash
600903d35da212b01407929faf61b2b67de6a1ca0b5f0e4617cec1ebf4cecdc6